Efficacy and safety of PD-1 and PD-L1 inhibitors in advanced colorectal cancer: a meta-analysis of randomized controlled trials

Efficacy and safety of PD-1 and PD-L1 inhibitors in advanced colorectal cancer: a meta-analysis of randomized controlled trials

Abstract Background PD-1 and PD-L1 inhibitors have emerged as promising therapies for advanced colorectal cancer (CRC), but their efficacy and safety profiles require further evaluation. This meta-analysis aims to assess the efficacy and safety of PD-1/PD-L1 inhibitors in this patient population. Me...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenzi Wang, Yuan Liu, Kedi Wang, Liyan Ma
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Gastroenterology
Subjects:
PD-1
PD-L1
Colorectal cancer
Meta-analysis
Immunotherapy
Adverse events
Online Access:https://doi.org/10.1186/s12876-024-03554-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12876-024-03554-8

Similar Items